ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±ÖÜÎÄÁ¼£©ÓÉÐÂÐ͹Ú×´²¡¶¾£¨severe acute respiratory syndrome coronavirus 2£¬£¬£¬SARS-CoV-2£©Ñ¬È¾ËùÒýÆðµÄÐÂÐ͹Ú×´²¡¶¾·ÎÑ×£¨Coronavirus disease 2019£¬£¬£¬COVID-19£©Òѵ¼ÖÂÈ«ÇòÁè¼Ý600ÍòÈËéæÃü£¬£¬£¬¶ÔÈËÀ࿵½¡ÓëÉç»á¿ªÕ¹Ôì³ÉÁËÆÆËðÐÔÓ°Ïì¡£¡£¡£¡£¡£È»¶ø£¬£¬£¬Õë¶ÔCOVID-19µÄÌØÒìÐÔÒ©ÎïÈÔ½Ïȱ·¦£¬£¬£¬ÆäÖ÷ÒªÔ­ÒòÔÚÓÚÏÖÔÚ¶ÔSARS-CoV-2ÒýÆðºôÎüϵͳËðÉ˵ĻúÖÆÏàʶȱ·¦¡£¡£¡£¡£¡£

Ñ×Ö¢µÄʵÖÊÊÇÒ»ÖÖÃâÒß·ÀÓù·´Ó³£¬£¬£¬ËüÊÇ»úÌåÔÚÔâÊÜѬȾ»òΣÏÕÐԴ̼¤ºóËù¾ÙÐеı£»£»¤ÐÔ²½·¥¡£¡£¡£¡£¡£ÔÚºôÎüµÀ£¬£¬£¬Ñ×֢ͨ³£ÆðʼÓÚÉÏƤϸ°û¶ÔÈëÇÖ²¡Ô­ÌåµÄʶ±ðÀú³Ì£¬£¬£¬¶Ôά³ÖºôÎüϵͳÎÈ̬ƽºâ¾ßÓÐÊ®·ÖÖ÷ÒªµÄÒâÒå¡£¡£¡£¡£¡£È»¶ø£¬£¬£¬Ñ×Ö¢·´Ó³Èôʧȥ¿ØÖÆת»¯Îª³ÖÐø¶øÌ«¹ýµÄ²¡ÀíÐÔ·´Ó³£¬£¬£¬½«Ôì³ÉÑÏÖصIJ»Á¼Ð§¹û¡£¡£¡£¡£¡£Òò´Ë£¬£¬£¬ÉîÈë̽ÌÖ»úÌåÎÈ̬ʧºâÓëÑ×֢ǨÑÓ²»ÓúµÄ»úÖÆ£¬£¬£¬¾ßÓÐÖ÷ÒªµÄÀíÂÛÓëÁÙ´²×ª»¯ÒâÒå¡£¡£¡£¡£¡£

ÈÕÇ°£¬£¬£¬ÖÜÎÄÁ¼½ÌÊÚÍŶÓÓëÖÓÄÏɽԺʿÍŶÓÏàÖú£¬£¬£¬ÔÚSARS-CoV-2Ö²¡»úÀí·½ÃæÈ¡µÃÖ÷ҪϣÍû¡£¡£¡£¡£¡£¸ÃÁªºÏÍŶÓʹÓõçÐÄÀíѧ¡¢¡¢·Ö×ÓÉúÎïѧ¡¢¡¢Ï¸°ûÉúÎïѧµÈʵÑéÊÖÒÕ£¬£¬£¬ÉîÈëÆÊÎöÁËϸ°ûÄÚÂÈÀë×Ó×÷Ϊ²¡ÀíÐÔµÚ¶þÐÅʹ½éµ¼ÁËCOVID-19ÆøµÀÑ×֢ǨÑÓ²»ÓúµÄ²¡Àí»úÖÆ£¬£¬£¬Ïà¹ØÑо¿Ð§¹ûÒÔ¡°SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl^? accumulation in respiratory epithelium¡±ÎªÌâ½ÒÏþÔÚ×ÔÈ»³öÊ鼯ÍÅ£¨NPG£©ÆìϹú¼ÊȨÍþѧÊõÆÚ¿¯¡¶ÐźÅתµ¼Óë°ÐÏòÖÎÁÆ£¨Signal Transduction and Targeted Therapy£©¡·ÉÏ£¬£¬£¬²¢ÒÔµ±ÆÚ·âÃæ¹ÊÊÂչʾ¡£¡£¡£¡£¡£

ͼ1 Signal Transduction and Targeted Therapy 2022ÄêµÚ8ÆÚ·âÃæ

·âÃæͼƬ½«ºôÎüµÀÉÏƤϸ°ûÃè»æΪһ¸öÌÒÔ´Ñþ³Ø£¬£¬£¬ÆäÖдú±íÂÈÀë×ӵĺÓÁ÷ͨÏ꾡°ûĤ³ÇǽÉϵÄÂÈÀë×ÓͨµÀCFTR´óÃÅÁ÷³ö£»£»µ±SARS-CoV-2ѬȾʱ£¬£¬£¬CFTR´óÃŹرÕ£¬£¬£¬´Ó¶øµ¼ÖÂÂÈÀë×Ó»ýÀÛ·ºÀÄÓëÑ×Ö¢·ç±©µÄ±¬·¢

¸ÃÑо¿ÒÔºôÎüµÀÉÏƤϸ°ûÖêºÍÔ­´ú×÷ÓýµÄÈ˺ôÎüµÀÉÏƤϸ°ûΪÌåÍâÑо¿Ä£×Ó£¬£¬£¬Á¬ÏµÆøµÀÄÚµÎ×¢SARS-CoV-2²¡¶¾ÂÑ°×Óë»î²¡¶¾¹¥¶¾µÄСÊóÔÚÌåÄ£×Ó£¬£¬£¬·¢Ã÷SARS-CoV-2ºËÒ¿ÇÂѰ׿ÉÓëËÞÖ÷ϸ°ûSmad3ÂÑ°×»¥×÷£¬£¬£¬Í¨¹ýÕÙļmicroRNA-145½éµ¼ÂÈÀë×ÓͨµÀÄÒÐÔÏËά»¯¿çĤ´«µ¼µ÷ÀíÒò×Ó£¨cystic fibrosis transmembrane conductance regulator£¬£¬£¬CFTR£©µÄ±í´ïϵ÷£¬£¬£¬´Ó¶øÒÖÖÆÁË¿çÉÏƤÂÈÀë×ÓµÄÉø͸»î¶¯¡£¡£¡£¡£¡£¼øÓÚÂÈÀë×ÓÉø͸ÊÜ×èºÜ¿ÉÄܻᵼÖÂϸ°ûÄÚÂÈÀë×ÓÎÈ̬ʧºâ£¬£¬£¬¸ÃÑо¿½øÒ»²½Í¨¹ýÏÔ΢Àë×Ó³ÉÏñÊÖÒÕ£¬£¬£¬·¢Ã÷SARS-CoV-2ºËÒ¿ÇÂѰ״̼¤¿ÉÒýÆðºôÎüµÀÉÏƤϸ°ûÄÚÂÈÀë×ÓŨ¶ÈÒì³£Éý¸ß£¬£¬£¬½ø¶øͨ¹ý¼¤»îÏÂÓεÄÂÈÀë×ÓÃô¸ÐÂѰסª¡ªÑªÇåÌÇƤÖʼ¤Ëص÷Àí¼¤Ã¸1£¨serum glucocorticoid regulated kinase 1£¬£¬£¬SGK1£©½éµ¼NF-¦ÊBÐźÅͨ·»î»¯£¬£¬£¬ÓÕµ¼Ñ×Ö¢·´Ó³µÄ±¬·¢¡£¡£¡£¡£¡£ÁíÒ»·½Ã棬£¬£¬SARS-CoV-2ºËÒ¿ÇÂÑ°×»¹¿ÉÒÔͨ¹ýNF-¦ÊBÒÀÀµµÄ;¾¶½éµ¼Á×Ëá¶þõ¥Ã¸4£¨phosphodiesterase 4£¬£¬£¬PDE4£©µÄ±í´ïÉϵ÷£¬£¬£¬½µµÍϸ°ûÄÚcAMPˮƽ£¬£¬£¬½øÒ»²½ÒýÆðCFTR¹Ø±Õ£¬£¬£¬´Ùʹϸ°ûÄÚÂÈÀë×ÓŨ¶Èά³ÖÔÚ¸ßˮƽ£¬£¬£¬´Ó¶øµ¼ÖÂÑ×Ö¢·´Ó³Ç¨ÑÓ²»Óú¡£¡£¡£¡£¡£ÓëÖ®Ïà·´£¬£¬£¬ÒÖÖÆ/ÇóýSGK1£¬£¬£¬»òÓèÒÔPDE4ÒÖÖƼÁ¸ÉÔ¤£¬£¬£¬¾ù¿ÉÒÔÏÔÖøÒÖÖÆSARS-CoV-2ºËÒ¿ÇÂѰ״̼¤ËùÒýÆðµÄ³ÖÐøÐÔÆøµÀÑ×Ö¢¡£¡£¡£¡£¡£

ͼ2 ϸ°ûÄÚÂÈÀë×Óµ÷¿ØSARS-CoV-2ËùÖºôÎüÉÏƤÑ×Ö¢·´Ó³µÄ»úÖÆģʽ

×ÛÉÏËùÊö£¬£¬£¬¸ÃÑо¿ÊÂÇéÊǹú¼Ê¹æÄ£ÄÚÂÊÏȱ¨µÀµÄϵͳÐÔÐðÊöϸ°ûÄÚÂÈÀë×Ó¼°ÆäÏÂÓÎÐźÅÍøÂçÔÚ²¡¶¾Ñ¬È¾ËùÖºôÎüϵͳËðÉËÖеÄ×÷ÓûúÖÆÑо¿£¬£¬£¬¶ÔCOVID-19µÄÐÂÒ©Ñз¢ÓëÖÎÁÆÕ½ÂÔ̽Ë÷¾ßÓÐÖ÷ÒªµÄÀíÂÛÖ¸µ¼ÒâÒå¡£¡£¡£¡£¡£

¸ÃÑо¿ÊÂÇéΪÖÜÎÄÁ¼½ÌÊÚÍŶӽüÄêÀ´ÏµÁÐÑо¿ÊÂÇéµÄÑÓÐøЧ¹û¡£¡£¡£¡£¡£ÔÚ2015Äê½ÒÏþÓÚÃÀ¹ú¹ú¼Ò¿ÆѧԺԺ¿¯Proc Natl Acad Sci U S AµÄÂÛÎÄÖУ¬£¬£¬ÖÜÎÄÁ¼½ÌÊÚÓëÂ×ÕÕÈÙ½ÌÊÚÏàÖú£¬£¬£¬·¢Ã÷¸ÕµØ¹­ÐγæѬȾ¿ÉÒýÆðºôÎüµÀÉÏƤϸ°ûÂÈÀë×ÓתÔËÊÜ×è^[1]¡£¡£¡£¡£¡£ÔÚ2018Äê½ÒÏþÓÚNPGÆìÏÂÃâÒßѧ¹ú¼ÊȨÍþÆÚ¿¯Mucosal ImmunolµÄÂÛÎÄÖУ¬£¬£¬ÖÜÎÄÁ¼½ÌÊÚ¼°ÍŶÓÖ÷¸ÉÕÅÒÕÁÖÌØƸ¸±Ñо¿Ô±ÀÖ³ÉÅжϳöÁËÒ»ÖÖÐÂÐ͵ÄÂÈÀë×Ó¸ÐÓ¦ÂÑ°×SGK1£¬£¬£¬²¢ÏµÍ³ÐԵزûÊÍÁËϸ°ûÄÚÂÈÀë×ÓÔÚϸ¾úѬȾËùÖÂÂýÐÔÆøµÀÑ×Ö¢ÐÔ¼²²¡£¡£¡£¡£¡£¨ÌØÊâÊÇÖ§Æø¹ÜÀ©ÕÅÖ¢£©ÖеÄÑ×Ö¢ÐźÅתµ¼×÷Óü°Æä·Ö×Ó»úÖÆ^[2]¡£¡£¡£¡£¡£ÒÔºóÓÚ2019¡¢¡¢2021Äê»®·Ö½ÒÏþÓÚ¼ÄÉú³æѧ¹ú¼ÊȨÍþÆÚ¿¯Int J ParasitolÓëPLoS Negl Trop DisµÄ2ƪÂÛÎÄÖУ¬£¬£¬¸ÃÑо¿ÍŶӽøÒ»²½ÑéÖ¤ÁËϸ°ûÄÚÂÈÀë×ÓÒì³£»£»ýÀÛÔÚÒõµÀëµÎ³æѬȾËùÖÂÉúÖ³µÀÉÏƤËðÉËÖÐͬÑùÊ©Õ¹ÁËÖ÷ÒªµÄ×÷ÓÃ^[3-4]¡£¡£¡£¡£¡£Á¬Ïµ±¾Ñо¿Ð§¹û£¬£¬£¬Ï¸°ûÄÚÂÈÀë×ÓÒì³£ÀÛ»ýÆձ鱣´æÓÚ²¡Ô­ÌåѬȾµÄÀú³ÌÖУ¬£¬£¬ÕâΪ¸ÃÑо¿ÍŶÓËùÌá³öµÄϸ°ûÄÚÂÈÀë×Ó×÷Ϊ²¡ÀíÐÔµÚ¶þÐÅʹµÄ¿´·¨ÌṩÁ˼áʵµÄÀíÂÛÒÀ¾Ý¡£¡£¡£¡£¡£ÏìÓ¦µØ£¬£¬£¬ÒÔϸ°ûÄÚÂÈÀë×Ó¼°ÆäÏÂÓÎÐźÅÍøÂçΪ°ÐµãµÄÕ½ÂÔ»ò¿ÉΪ¶àÖÖÂýÐÔÑ×Ö¢ÐÔ¼²²¡µÄÖÎÁÆÌṩеÄ̽Ë÷Æ«Ïò¡£¡£¡£¡£¡£

¸ÃÑо¿ÂÛÎÄͨѶ×÷ÕßΪngµç×ÓÓÎÏ·ÉúÃü¿ÆѧѧԺÖÜÎÄÁ¼½ÌÊÚ¡¢¡¢ÕÅÒÕÁÖÌØƸ¸±Ñо¿Ô±Óë¹ãÖݺôÎü¿µ½¡Ñо¿ÔºÖÓÄÏɽԺʿ¡£¡£¡£¡£¡£µÚÒ»×÷ÕßΪngµç×ÓÓÎÏ·ÉúÃü¿ÆѧѧԺ³ÂÀÚ¡¢¡¢Çñ׿¶û²©Ê¿¼°¹ãÖÝÒ½¿Æ´óѧ¹Øΰ½ÜÑо¿Ô±¡¢¡¢Ð콨°î²©Ê¿¡£¡£¡£¡£¡£ngµç×ÓÓÎÏ·ÉúÃü¿ÆѧѧԺÂ×ÕÕÈÙ½ÌÊÚ¡¢¡¢Ò¶¿ËÄѸ±½ÌÊÚΪ¸ÃÊÂÇéÌṩÁËÖ÷ÒªÖ§³Ö¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬ngµç×ÓÓÎÏ·ÉúÃü¿ÆѧѧԺÁõ·å¸±½ÌÊÚΪ¸ÃÊÂÇéÖÐÂÑ°×ÖÊ-ÂÑ°×ÖÊ»¥×÷ʵÑéÌṩÁËÊÖÒÕÖ¸µ¼Òâ¼û¡£¡£¡£¡£¡£¸ÃÊÂÇé»ñµÃ¹ãÖݺôÎü¿µ½¡Ñо¿Ôº¿ª·Å¿ÎÌ⣨Öйúºã´ó¼¯ÍÅËùÌṩ×ʽð×ÊÖú£©¡¢¡¢¹ã¶«Ê¡ÖÓÄÏɽҽѧ»ù½ð»á¿ÆÑÐ×ÊÖú»ù½ð¼°¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðµÈÏîÄ¿µÄ×ÊÖú¡£¡£¡£¡£¡£

ÂÛÎÄÁ´½Ó£ºhttps://www.nature.com/articles/s41392-022-01048-1

²Î¿¼ÎÄÏ×£º

[1] Guo HM, Gao JM, Luo YL, Wen YZ, Zhang YL, Hide G, Zhou WL, Ayala FJ, Lun ZR. Infection by Toxoplasma gondii, a severe parasite in neonates and AIDS patients, causes impaired anion secretion in airway epithelia. Proc Natl Acad Sci U S A. 2015 Apr 7; 112(14): 4435-40.

[2] Zhang YL, Chen PX, Guan WJ, Guo HM, Qiu ZE, Xu JW, Luo YL, Lan CF, Xu JB, Hao Y, Tan YX, Ye KN, Lun ZR, Zhao L, Zhu YX, Huang J, Ko WH, Zhong WD, Zhou WL, Zhong NS. Increased intracellular Cl^? concentration promotes ongoing inflammation in airway epithelium. Mucosal Immunol. 2018 Jul; 11(4): 1149-1157.

[3] Xu JB, Zhang YL, Huang J, Lu SJ, Sun Q, Chen PX, Jiang P, Qiu ZE, Jiang FN, Zhu YX, Lai DH, Zhong WD, Lun ZR, Zhou WL. Increased intracellular Cl^? concentration mediates Trichomonas vaginalis-induced inflammation in the human vaginal epithelium. Int J Parasitol. 2019 Aug; 49(9): 697-704.

[4] Xu JB, Lu SJ, Ke LJ, Qiu ZE, Chen L, Zhang HL, Wang XY, Wei XF, He S, Zhu YX, Lun ZR, Zhou WL, Zhang YL. Trichomonas vaginalis infection impairs anion secretion in vaginal epithelium. PLoS Negl Trop Dis. 2021 Apr 16; 15(4): e0009319.